Page 5 - Biomedical Technology News Today

The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects a deal to acquire Horizon Therapeutics to close by mid-December.

/PRNewswire/ -- The infusion pump market is estimated to grow by USD 5,085.17 million at a CAGR of 7.27% from 2022 to 2027. Discover some insights on market...

Longer leukocyte telomere length is associated with cardiac size, function, and lower heart failure risk in a middle-aged population.

At the moment, the number of medical interns in the country is overwhelmingly high due to private universities that are now producing close to 2,000 medical officers (MO) every year

Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential drugs.

The amalgamation of Malumfashi Students Old Boys Union and the concerned Malumfashi Progressive Group have jointly called on Katsina State

South Koreas Samsung Biologics announced on Tuesday two deals with Pfizer worth around a combined 1.2 trillion won ($921.38 million) to manufacture products for the US pharmaceutical giant.

/PRNewswire/ -- Dr. Marvin H. Caruthers of the University of Colorado, Boulder, has won the inaugural Richard N. Merkin Prize in Biomedical Technology for...

In patients with gliomas bearing IDH1/2 mutations, the brain barrier-crossing oral drug vorasidenib kept tumors at bay, and could be used instead of more toxic chemotherapies and radiation.

Biotech company Alnylam Pharmaceuticals filed new lawsuits against Pfizer Inc and Moderna Inc in Delaware federal court, again claiming that the companies COVID-19 vaccines infringe its patents.